tm logo

Monitor this mark

View On USPTO

FAZACLO (CLOZAPINE, USP) ORALLY DISINTEGRATING TABLETS
Live/Registered
REGISTERED AND RENEWED

on 17 Oct 2016

Last Applicant/ Owned by

JAZZ PHARMACEUTICALS IRELAND LIMITED

FIFTH FLOOR WATERLOO EXCHANGE

DUBLIN

IE

Serial Number

78411481 filed on 30th Apr 2004

Registration Number

3146363 registered on 19th Sep 2006

in the Principal Register

Correspondent Address

Timothy D. Sitzmann

Timothy D. Sitzmann

Capella Tower Suite 3500

225 South Sixth Street

Minneapolis MN 55402

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

FAZACLO (CLOZAPINE, USP) ORALLY DISINTEGRATING TABLETS

Pharmaceutical preparations for the treatment of schizophrenia

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of schizophrenia

First Use Date in General

31st Jul 2004

First Use Date in Commerce

31st Jul 2004

Mark Details

Serial Number

No 78411481

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

01.05.04 -

Suns with rays

26.01.21 -

Circles that are totally or partially shaded

26.01.31 -

Five or more circles

Legal History

Show more

Status DateAction Taken
26th May 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
24th Jul 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
15th Jun 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
15th Jun 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
17th Oct 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
17th Oct 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
17th Oct 2016REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
17th Oct 2016REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03rd Aug 2016TEAS SECTION 8 & 9 RECEIVED
19th Sep 2015COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED